The burgeoning cannabis field is an exciting frontier for patients and physicians, but it’s also fraught with liabilities and unknowns. Constantly changing state and local regulations make the prospect of recommending medical marijuana to patients a daunting, or even risky, prospect for busy doctors—even if they might otherwise be open to cannabis as a viable and powerful treatment option.
MarijuanaDoctors.com is hoping to flip that script. As the foremost provider of up-to-date, relevant information for all things medical marijuana, we’re thrilled to announce our new partnership with Extra Step Assurance (ESA), another comprehensive leader in the medical marijuana space. This collaboration was forged out of a common desire: to provide doctors and patients with the resources needed to make medical marijuana a legitimate new field for consideration—and we found no better allies than the educators and experts at ESA.
ESA is bringing the highest possible standards of integrity, accountability, conformity, and safety to the medical cannabis industry. Their services include continuing medical education (CME) and certification for healthcare professionals, a national information call center, as well as standardization of industry best practices for doctors, dispensaries, and other cannabis-related businesses.
In particular, ESA’s Cannabis Medical Expertise (CME) training is designed for doctors, pharmacists, nurses, medical practitioners—or pretty much anyone interested in learning more about marijuana as medicine. Physicians seeking to recommend cannabis to their patients can receive CME credits, which some states require for doctors recommending medical marijuana, as well as certification through CME’s nationally-accredited courses (thus adding continuing education credit to their medical license) or, might simply be seeking more comfortability when discussing marijuana with their patients.
With on-site live events or webinars offered all across the nation (currently in 35 of 50 states, as well as over 13 countries across the globe), in CME courses participants will learn the intricacies of the body’s endocannabinoid system, methods and modes of ingestion, treatable conditions, terpene and strain information, and—importantly—the legal parameters involved with becoming a cannabis-certified practitioner in your local area.
CME courses are led by some of the world’s leading cannabis and medical professionals, and, depending on your desired levels of expertise, are available in convenient 2-hour, 4-hour, or 18-hour sessions.
As well, all CME content has been audited by the Accreditation Council for Continuing Medical Education (ACCME), along with several other universities and accrediting bodies such as the Ohio Osteopathic Association, the Ohio Nurses Association, CannMed, and other national conferences.
As clinical trials continue and research confirms and expands the use cases and benefits of medical marijuana, CME training will help you stay current and compliant with your state’s cannabis laws as they change. ESA stays on top of all developments in the field to ensure patient safety, as well as community and physician protection.
“This was an excellent conference; at every presentation there was practical information for me to take home and utilize in my practice.”
“I believe that all pharmacists, doctors and other medical professionals need to understand this medication and be ready to help patients…[CME] teaches the endocannabinoid system, which is a well-documented and researched system that has not been taught in medical or pharmacy schools.” -Ohio -RpH
“[It] covered all the big questions that clinicians new to medical cannabis would have, including myths and misinformation surrounding addiction and adverse effects, legal issues, treatments of various conditions, dosing considerations, and how to address impairment.” – R.Ph, PharmD, BCPS
“I came not planning to ever recommend—but left thinking I might.”
In addition, at the close of every Cannabis Medical Expertise (CME) training, participants are provided with:
Finally: cannabis’ designation as a Schedule 1 drug (though it’s on-the-march to be reclassified on a state-by-state basis) means it will continue to require rigorous reporting, record keeping, and accountability. ESA’s experience working with regulatory bodies and the DEA can guide doctors and dispensaries on how to become state-compliant—even before it’s required.
Through patient verification, resources, training, and a commitment to integrity, MJDocs.com and ESA are working hard to build confidence and trust among patients, doctors, and the larger community. Check out www.extrastepasurance.com to find out more.